Unraveling the biology of multiple myeloma disease: cancer stem cells, acquired intracellular changes and interactions with the surrounding micro-environment
- PMID: 18390410
- DOI: 10.1684/bdc.2008.0600
Unraveling the biology of multiple myeloma disease: cancer stem cells, acquired intracellular changes and interactions with the surrounding micro-environment
Abstract
Cancerogenesis is believed to be a multistep process composed of different alterations that drive the transformation of normal human cells into highly malignant derivatives. These changes include self-sufficiency in growth signals, insensitivity to growth-inhibitory signals, the evasion of programmed cell death, a limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis. Some evidence suggests that these cancer cells are derived from immature, proliferative precursors that feed the cancer cell compartment. Both, precursors and cancer cells, intensively interact with their surroundings, commonly described as their micro-environment. The processes above are also important in the biology of multiple myeloma, a malignant bone marrow disorder consisting of monoclonal plasma cells accumulation. In the current review we describe the biology of this disease, stressing the origin of myeloma cells, their acquired genetic changes and interactions with their bone marrow microenvironment.
Similar articles
-
Ion channels and the hallmarks of cancer.Trends Mol Med. 2010 Mar;16(3):107-21. doi: 10.1016/j.molmed.2010.01.005. Epub 2010 Feb 16. Trends Mol Med. 2010. PMID: 20167536 Review.
-
MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype.Endocr Relat Cancer. 2010 Jan 29;17(1):F51-75. doi: 10.1677/ERC-09-0222. Print 2010 Mar. Endocr Relat Cancer. 2010. PMID: 19843580 Review.
-
Transcription factors: their potential as targets for an individualized therapeutic approach to cancer.Cancer Gene Ther. 2009 Feb;16(2):103-12. doi: 10.1038/cgt.2008.73. Epub 2008 Oct 10. Cancer Gene Ther. 2009. PMID: 18846113 Review.
-
NF-kappaB in solid tumors.Biochem Pharmacol. 2006 Oct 30;72(9):1142-52. doi: 10.1016/j.bcp.2006.07.032. Epub 2006 Sep 7. Biochem Pharmacol. 2006. PMID: 16956585 Review.
-
Angiogenesis in multiple myeloma.Eur J Cancer. 2006 Jul;42(11):1581-90. doi: 10.1016/j.ejca.2006.02.017. Epub 2006 Jun 23. Eur J Cancer. 2006. PMID: 16797965 Review.
Cited by
-
BAFF and APRIL as TNF superfamily molecules and angiogenesis parallel progression of human multiple myeloma.Ann Hematol. 2014 Apr;93(4):635-44. doi: 10.1007/s00277-013-1924-9. Epub 2013 Oct 19. Ann Hematol. 2014. PMID: 24141333 Free PMC article.
-
Monocyte chemotactic protein 1 (MCP-1) modulates pro-survival signaling to promote progression of head and neck squamous cell carcinoma.PLoS One. 2014 Feb 19;9(2):e88952. doi: 10.1371/journal.pone.0088952. eCollection 2014. PLoS One. 2014. PMID: 24586454 Free PMC article.
-
Targeting the biophysical properties of the myeloma initiating cell niches: a pharmaceutical synergism analysis using multi-scale agent-based modeling.PLoS One. 2014 Jan 27;9(1):e85059. doi: 10.1371/journal.pone.0085059. eCollection 2014. PLoS One. 2014. PMID: 24475036 Free PMC article.
-
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.Blood. 2014 Dec 11;124(25):3748-57. doi: 10.1182/blood-2014-05-576116. Epub 2014 Oct 15. Blood. 2014. PMID: 25320245 Free PMC article.
-
SGK3 (CISK) may induce tumor angiogenesis (Hypothesis).Oncol Lett. 2015 Jul;10(1):23-26. doi: 10.3892/ol.2015.3182. Epub 2015 May 6. Oncol Lett. 2015. PMID: 26170971 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical